SCAPIN-923: ADDITION OF COMPANY CONTROLLED BY MITSUI FAMILY AND SUBSIDIARY OF SUMITOMO HONSHA, LTD., TO THE SCHEDULE OF RESTRICTED CONCERNS

GENERAL HEADQUARTERS
SUPREME COMMANDER FOR THE ALLIED POWERS

APO 500
4 May 1946

AG 004 (4 May 46) ESS/AC
(SCAPIN-923)

MEMORANDUM FOR

IMPERIAL JAPANESE GOVERNMENT.

THROUGH

Central Liaison Office, Tokyo.

Subject

Addition of Company Controlled by Mitsui Family and Subsidiary of Sumitomo Honsha, Ltd., to the Schedule of Restricted Concerns.

1. Reference is made to the following Memoranda for the Imperial Japanese Government from the Supreme Commander for the Allied Powars:
a. AG 319.1 (22 Oct 45) ESS/IE (SCAIN - 177), subject: “Reports to be Made by Certain Business Firms.”
b. AG 004 (31 Oct 45) ESS (SCAPIN-215), subject: “Sale or Transfer of Securities of Certain Business Firms.”
c. AG 004 (8 Dec 45) ESS/AC (SCAPIN-403), subject: “Eatablishment of a Schedule of Restricted Concerns.”
d. AG 300.8 (8 Dec 45) ESS/AC (SCAPIN-408), subject: “Regulations Affecting Restricted Concerns.”
e. AG 123 (15 Jan 46) ESS/FI (SCAPIN-599), subject: “Restriction on Dividend Payments.”
f. AG 319.1 (19 Jan 46) ESS/AC (SCAPIN-625), subject: “Reports to be Made by Certain Business Firms.”
g. AG 150 (23 Feb 46) ESS/AC (SCAPIN-767), subject: “War Damage and Government Indemnity Claims of Companies on the Schedule of Restricted Concerns.”
2. Kaken Drug, Ltd., a company controlled by the Mitsui family, and the Oriental Nitrogen Industry Company, Ltd., a subsidiary of Sumitomo Honsha, Ltd., are hereby added to the Schedule of Restricted Concerns referred to in paragraph 1c, above.
3. The Imperial Japanese Government will take immediate action to assure that the concerns named in paragraph 2, above, shall comply with the provisions of and make reports required by reference Memoranda listed in paragraph 1, above. Wherever reference is made in inclosure 1 and inclosure 2 to Memorandum for the Imperial Japanese Government referred to in paragraph 1a, above, to the year 1944, it shall be amended to read 1945.

FOR THE SUPREME COMMANDER:

B.M.FICHI
Brigadiar General,AGD,
Adjutant General

MEMO FOR RECORD: (SCAPIN - 923)
24 April 1946
1. Pursuant to the policy set forth in Joint Chiefs of Staff Directive 1380/15, dated 3 November 1945, investigations are being made of concerns which are not on the Schedule of Restricted Concerns, inclosure to SCAP Memorandum for the Imperial Japanese Government, AG 004 (8 Dec 45) ESS/AC (SCAPIN-403), subject: "Establishment of Schedule of Restricted Concerns."
2. Kaken Drug, Ltd., a company controlled by the Mitsui family, and Oriental Nitrogen Industry Company, Ltd., a subsidiary of Sumitomo Honsha, Ltd, are considered subsidiaries as defined by SCAP Memorandum, AG 319.1 (22 Oct 45) ESS/IE (SCAPIN-177), Subject: "Reports to be Made by Certain Business Firms," and should, therefore, be placed on the Schedule of Restricted Concerns referred to in paragraph 1, above.
Company Percentage of Control by Mitsui Family
Kaken Drug, Ltd. 30
Subsidiary Percentage of Control by Sumitomo Honsha, Ltd.
Oriental Nitrogen Industry Company, Ltd. 12.5
3. The interests of USAFIK have been considered. This action does not affect the Korean area.
4. This is considered an administrative matter.
5. Concurrences: Industrial Division, ESS (Lt. Col. J. A. O'Hearn); Legal Division, ESS (Major E. R. Minnich).
/t/s/J. McI. H.